Tumour marker requesting in primary care and the role of the laboratory

Journal of Clinical Pathology

Volumn 64, Issue 5, 2011, Pages 443-446

  Walker, Patrick L C ^a   Crook, Martin ^a  

^a UNIVERSITY HOSPITAL LEWISHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN; CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

BIOCHEMISTRY; COMPUTER PROGRAM; EVIDENCE BASED PRACTICE CENTER; HUMAN; LABORATORY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; REVIEW;

BENCHMARKING; CLINICAL CHEMISTRY TESTS; DATA MINING; EVIDENCE-BASED MEDICINE; HUMANS; INTERPROFESSIONAL RELATIONS; MEDICAL LABORATORY SCIENCE; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; PRIMARY HEALTH CARE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 79955113835     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2010.085357     Document Type: Review

References (11)

1. An Independent Review for the Department of Health. Chaired by Lord Carter of Coles. Report of the Second Phase of the Independent Review of NHS Pathology Services in England, 2008.
2. Rao GG, Crook M, Tillyer ML. Pathology tests: is the time for demand management ripe at last? J Clin Pathol 2003;56:243-8.
3. Fryer AA, Hanna FW. Managing demand for pathology tests: financial imperative or duty of care? Ann Clin Biochem 2009;46:435-7.
4. Sturgeon CM, Lai LC, Duffy MJ. Serum tumour markers: how to order and interpret them. BMJ 2009;339:852-8.
5. Sturgeon CM, Duffy MJ, Stenaman UH, et al. National Academy of Clinical Biochemisty laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast and ovarian cancers. Clin Chem 2008;54:e11-79.
6. Kilpatrick ES, Lind MJ. Appropriate requesting of serum tumour markers. BMJ 2009;339:859-60.
7. NHS Cancer Screening Programmes. Prostate Cancer Risk Management. http://www.cancerscreening.nhs.uk/prostate/index.html (accessed 10 Dec 2009).
8. Durand-Zaleski I, Rymer JC, Roudot-Thoraval F. Reducing unnecessary laboratory use with new test request form: example of tumour markers. Lancet 1993;342:150-3. (Pubitemid 23200444)
9. Jansenns PM. Managing the demand for laboratory testing: options and opportunities. Clin Chim Acta 2010;411:1596-602.
10. McDonnell M; on behalf of The Northern Ireland Regional Audit Group. An audit of tumour marker requests in Northern Ireland. Ann Clin Biochem 2004;41:378-84.
11. Franceschini R, Trevisiol C, Dittadi R, et al. Tumour markers requesting pattern with regards to different organizational settings in Italy: a survey of hospital laboratories. Ann Clin Biochem 2009;46:316-21.